Research News and Research

RSS

Late abortions can increase risk of preterm birth and low birthweight

New research indicates that a prior induced abortion poses only a very small risk of negative effects on births from subsequent pregnancies, but the risk is higher if the abortion is performed later in the pregnancy.

4 Mar 2020

Patients with rheumatoid arthritis more likely to quit smoking, shows study

Smoking doubles the risk of developing rheumatoid arthritis and continuing to smoke after being diagnosed has negative effects on patients.

4 Mar 2020

Know your ions – overcoming the limits of HPLC with ion chromatography

What’s the difference between High Performance Liquid Chromatography and Ion Chromatography? What are the capabilities and limitations of each technique? Knowing these differences can actually make a huge difference.

From Metrohm Middle East FZC 4 Mar 2020

Study: Bereaved individuals face higher risk of dying from melanoma

Individuals who experience the loss of a partner are less likely to be diagnosed with melanoma but face an increased risk of dying from the disease, according to research published in the British Journal of Dermatology.

4 Mar 2020

A new, promising method for developing drugs that target, block macropinocytosis

With drug resistance a major challenge in the fight against cancer, a discovery by University of California, Irvine biologists could offer new approaches to overcoming the obstacle.

3 Mar 2020

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

Ocugen, Inc., a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, announced today the publication in Nature Gene Therapy of preclinical data of nuclear hormone receptor gene NR2E3 as a genetic modifier and therapeutic agent to treat multiple retinal degenerative diseases.

3 Mar 2020

A fierce national debate over the implementation of Affordable Care Act

The fierce national debate over health care reform includes deep divisions over the appropriate roles of the federal and state governments. For example, while Sen Bernie Sanders (I-VT) calls for expanding the federal Medicare program to cover all Americans, the Trump administration pushes for the states to have far greater authority.

3 Mar 2020

Evaluating the safety and effectiveness of investigational drug to manage pediatric myopia

SUNY College of Optometry will take part in a multi-center US clinical trial sponsored by Eyenovia, Inc. to evaluate the safety and effectiveness of an investigational drug, MicroPine, to help slow myopic progression in children 3 to 12 years old.

3 Mar 2020

Drug prices beat inflation all the way even with discounts

A new study published in the journal JAMA in March 2020 shows how prescription drug prices are rising faster than the rate of inflation. The decade-long trend reflects a threefold higher rise in brand-name drug prices compared to inflation if all drugs are lumped together.

3 Mar 2020

Study suggests guidelines to enhance content of educational videos on chronic conditions

Many people with chronic health conditions search social media, including YouTube videos, to learn more about how to manage their diagnoses. But these videos differ in how well they communicate information and hold viewers' attention.

3 Mar 2020

New UCLA study reveals mechanism underlying breathing rhythm generation

Breathing propels everything we do--so its rhythm must be carefully organized by our brain cells, right?

3 Mar 2020

Chemists develop promising molecular tool to target cell immortality's underlying gears

One of the hallmarks of cancer is cell immortality. A Northwestern University organic chemist and his team now have developed a promising molecular tool that targets and inhibits one of cell immortality's underlying gears: the enzyme telomerase.

3 Mar 2020

Novel drug to arrest antibiotic resistance by preventing micro-evolution

Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.

3 Mar 2020

Inhibiting energy production in immune T-cells allows some tumors to escape treatment

A small molecule that inhibits energy production in immune T-cells allows some tumors to escape treatment with an immunotherapy called PD-1 blockade therapy, says a study in mice published today in eLife.

3 Mar 2020

Big Pharma more profitable than most other large public firms

A large study published in the journal JAMA in March 2020 reports that large pharmaceutical companies make a much larger profit from their products than other large public companies. This is important because it indicates the potential to reduce drug prices while sustaining competitive and innovative drug development and marketing.

3 Mar 2020

Observation of telomerase activity at a single-molecule level using 'optical tweezers'

Stem cells involved in replenishing human tissues and blood depend on an enzyme known as telomerase to continue working throughout our lives. When telomerase malfunctions, it can lead to both cancer and premature aging conditions.

3 Mar 2020

Profit-prediction system may reduce suicide rates among indebted farmers in India

Researchers at Penn State are taking steps to address the alarming rate of suicides among indebted farmers in India, by developing a deep-learning algorithm as the first step in a decision-support system that could predict future market values of crops.

3 Mar 2020

UAB research reveals hydrogen sulfide as new culprit for deadly tuberculosis

A new culprit -- hydrogen sulfide -- has been found for the deadly infectious disease tuberculosis. Hydrogen sulfide gas is known for its rotten egg smell, yet it has normal physiological roles in the human body to communicate among cells.

3 Mar 2020

The research and development costs of a new drug

Many recent studies have focused on how much it costs to bring a new drug to market in the light of increasing drug prices. Estimates range from $314 million to $2.8 billion. Most of this was based on proprietary data and was, therefore, not verifiable independently, attracting much criticism.

3 Mar 2020

Study explores ways to predict patients' risk of future readmissions

Recurrent, unplanned readmissions to the hospital -- which happen when patients return shortly after discharge and are readmitted for the same or a related condition -- are a challenge worldwide.

3 Mar 2020

Research News and Research

Late abortions can increase risk of preterm birth and low birthweight

Patients with rheumatoid arthritis more likely to quit smoking, shows study

Know your ions – overcoming the limits of HPLC with ion chromatography

Study: Bereaved individuals face higher risk of dying from melanoma

A new, promising method for developing drugs that target, block macropinocytosis

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

A fierce national debate over the implementation of Affordable Care Act

Evaluating the safety and effectiveness of investigational drug to manage pediatric myopia

Drug prices beat inflation all the way even with discounts

Study suggests guidelines to enhance content of educational videos on chronic conditions

New UCLA study reveals mechanism underlying breathing rhythm generation

Chemists develop promising molecular tool to target cell immortality's underlying gears

Novel drug to arrest antibiotic resistance by preventing micro-evolution

Inhibiting energy production in immune T-cells allows some tumors to escape treatment

Big Pharma more profitable than most other large public firms

Observation of telomerase activity at a single-molecule level using 'optical tweezers'

Profit-prediction system may reduce suicide rates among indebted farmers in India

UAB research reveals hydrogen sulfide as new culprit for deadly tuberculosis

The research and development costs of a new drug

Study explores ways to predict patients' risk of future readmissions

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery